Palvella Therapeutics Named Healthcare & Life Sciences Company of the Year at the Philadelphia Alliance for Capital and Technologies (PACT) Ecosystem Awards
Palvella Therapeutics, a Nasdaq-listed clinical-stage biopharmaceutical company specializing in novel treatments for rare skin diseases and vascular malformations, has been named the Healthcare & Life Sciences Company of the Year at the 2026 PACT Ecosystem Awards. The award highlights Palvella's progress in advancing their QTORIN™ platform therapie…